Form 8-K · Current report
CRH plc 8-K, filed Oct 29, 2026
- Filed
- CIK
- 0000849395
- Accession no.
- 0000849395-26-000012
Summary
CRH reported third-quarter 2026 total revenues of $11.4 billion, up 3% year over year, while net income fell 22% to $1.2 billion and Adjusted EBITDA was flat at $2.7 billion; the company also completed its $8.5 billion Arcosa acquisition and announced a new share buyback program of up to $6 billion.
Key points
- CRH expects fiscal 2026 net income of $3.1 billion to $3.3 billion and Adjusted EBITDA of $7.8 billion to $8.0 billion.
- On October 23, 2026, CRH completed its acquisition of Arcosa, with Arcosa stockholders receiving $150.00 per share in cash for a total enterprise value of approximately $8.5 billion.
- CRH announced a quarterly dividend of $0.39 per share, a 5% increase, and a new share buyback program of up to $6 billion expiring at the end of 2030.
- CRH launched Velocity, a transformation initiative expected to deliver approximately $400 million in annual run-rate benefits by the end of 2028.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition. On October 29, 2026, CRH plc (the ‘Company’) issued a press release announcing the financial results of the Company for the fiscal quarter ended September 30, 2026. A copy of the announcement is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The Company will host an earnings conference call and webcast presentation to discuss its quarterly results on October 29, 2026, at 8:00 a.m. (EDT). Investors and members of the public can register for the conference call at www.crh.com/investors. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.